Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Molecular mechanisms involved in the antilipolytic action of insulin: phosphorylation and activation of a particulate adipocyte cAMP phosphodiesterase.

Manganiello VC, Smith CJ, Degerman E, Vasta V, Tornqvist H, Belfrage P.

Adv Exp Med Biol. 1991;293:239-48. Review. No abstract available.

PMID:
1662861
2.

Mechanisms for activation of the rat adipocyte particulate cyclic-GMP-inhibited cyclic AMP phosphodiesterase and its importance in the antilipolytic action of insulin.

Manganiello VC, Degerman E, Smith CJ, Vasta V, Tornqvist H, Belfrage P.

Adv Second Messenger Phosphoprotein Res. 1992;25:147-64. Review. No abstract available.

PMID:
1313257
3.

Type III cyclic nucleotide phosphodiesterases and insulin action.

Manganiello VC, Degerman E, Taira M, Kono T, Belfrage P.

Curr Top Cell Regul. 1996;34:63-100. Review. No abstract available.

PMID:
8646851
5.

Characterization of the cyclic nucleotide phosphodiesterase isoenzymes present in rat epididymal fat cells.

Schmitz-Peiffer C, Reeves ML, Denton RM.

Cell Signal. 1992 Jan;4(1):37-49.

PMID:
1571203
6.

Subcellular localization and biological function of specific cyclic nucleotide phosphodiesterases.

Manganiello VC.

J Mol Cell Cardiol. 1987 Oct;19(10):1037-40. Review. No abstract available.

PMID:
2830403
8.

Hormonal regulation of adipocyte particulate "low Km" cAMP phosphodiesterase.

Manganiello VC, Smith CJ, Newman AH, Rice K, Degerman E, Belfrage P.

J Cyclic Nucleotide Protein Phosphor Res. 1986-1987;11(7):497-511. Review. No abstract available.

PMID:
2450112
9.

Cyclic nucleotides and lipolysis.

Pohl SL.

Int J Obes. 1981;5(6):627-33.

PMID:
6274817
10.
11.

Phosphorylation and activation of hormone-sensitive adipocyte phosphodiesterase type 3B.

Degerman E, Landström TR, Wijkander J, Holst LS, Ahmad F, Belfrage P, Manganiello V.

Methods. 1998 Jan;14(1):43-53.

PMID:
9500857
12.

cGMP-inhibited phosphodiesterases (PDE3 gene family).

Degerman E, Belfrage P, Manganiello VC.

Biochem Soc Trans. 1996 Nov;24(4):1010-4. Review. No abstract available.

PMID:
8968502
13.

[Insulin-sensitive cAMP phosphodiesterases].

Fujita-Yamaguchi Y.

Seikagaku. 1990 Sep;62(9):1162-6. Japanese. No abstract available.

PMID:
2175332
14.

Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1).

Kakkar R, Raju RV, Sharma RK.

Cell Mol Life Sci. 1999 Jul;55(8-9):1164-86. Review.

PMID:
10442095
15.

Evidence that insulin and isoprenaline activate the cGMP-inhibited low-Km cAMP phosphodiesterase in rat fat cells by phosphorylation.

Degerman E, Smith CJ, Tornqvist H, Vasta V, Belfrage P, Manganiello VC.

Proc Natl Acad Sci U S A. 1990 Jan;87(2):533-7.

16.

Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the antilipolytic action of insulin.

Eriksson H, Ridderstråle M, Degerman E, Ekholm D, Smith CJ, Manganiello VC, Belfrage P, Tornqvist H.

Biochim Biophys Acta. 1995 Apr 6;1266(1):101-7.

PMID:
7718614
17.
18.

Identification of the insulin-regulated interaction of phosphodiesterase 3B with 14-3-3 beta protein.

Onuma H, Osawa H, Yamada K, Ogura T, Tanabe F, Granner DK, Makino H.

Diabetes. 2002 Dec;51(12):3362-7.

19.

Insulin and lipolytic hormones stimulate the same phosphodiesterase isoform in rat adipose tissue.

Boyes S, Loten EG.

Biochem Biophys Res Commun. 1989 Jul 31;162(2):814-20.

PMID:
2547376
20.

High and low gain switches for regulation of cAMP efflux concentration: distinct roles for particulate GC- and soluble GC-cGMP-PDE3 signaling in rabbit atria.

Wen JF, Cui X, Jin JY, Kim SM, Kim SZ, Kim SH, Lee HS, Cho KW.

Circ Res. 2004 Apr 16;94(7):936-43. Epub 2004 Feb 26.

Items per page

Supplemental Content

Write to the Help Desk